The co‐treatment of DOX and T. pratense (especially at the dose of 400 mg/kg) decreased the serum level of E2 (as a stimulant for breast tumor growth) and increased the serum levels of IL‐12 and IFN‐γ along with significant increments in serum GPx and tumor FRAP activities. This evidence concerns the gene IFNG and breast neoplasm.